Oakworth Capital’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
UCFA
VCM
VPM
MC
Oakworth Capital's RGEN Position: Q1 2026 in Review
Oakworth Capital held its Repligen (RGEN) position steady in Q1 2026 at 250 shares worth $29.5K. The position accounts for ﹤0.01% of the portfolio, ranked #534.
Oakworth Capital first reported a position in RGEN in Q1 2016 and has held it in 30 quarters since. The position peaked at $83K in Q3 2018. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.
- Oakworth Capital held 250 shares of Repligen worth $29.5K as of Q1 2026.
- Oakworth Capital left its Repligen share count unchanged in Q1 2026.
- Repligen made up ﹤0.01% of Oakworth Capital's portfolio in Q1 2026, its #534 holding.
- Oakworth Capital first reported a position in Repligen in Q1 2016 and has held it in 30 quarters since.
- Oakworth Capital's Repligen position peaked at $83K in Q3 2018.
- 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.
Based on Oakworth Capital's 13F filing for Q1 2026, filed 24 Apr 2026.